Audio Insights: Recent Episodes
Mayo Medical Laboratories
Mayo Clinic Laboratories is a global reference laboratory operating within Mayo Clinic's Department of Laboratory Medicine and Pathology.
"Get to Know MCS” is an internal podcast hosted by Curt Hanson, M.D., featuring the people and teams who expand Mayo Clinic knowledge to meet the needs of patients served through Mayo Collaborative Services.In this episode, Dr. Hanson interviews Dennis Mc Neil, senior director of international sales for MCL. They discuss Dennis' background and highlights from his long career with Mayo Clinic, what people might be surprised to learn about international business affairs, and the impact that MCL has on communities around the world.
How Does this Testing Improve Upon Previous Testing Approaches? by Mayo Medical Laboratories
What Clinical Action is Enabled by the Results of this Testing by Mayo Medical Laboratories
Leveraging The Laboratory Interview with Mike Baish and Nicole Kang by Mayo Medical Laboratories
In this "Chat with the Chair" podcast, William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic in Rochester, Minnesota, and President of Mayo Clinic Laboratories, sits down with Curtis Hanson, M.D., Chief Medical Officer of Mayo Clinic Laboratories, to discuss value-based medicine.
What Clinical Action Is Enabled by the Results of this Testing? by Mayo Medical Laboratories
William Morice, M.D., Ph.D., President of Mayo Clinic Laboratories (MCL)and Chair of the Department of Laboratory Medicine and Pathology (DLMP), reflects on his time as chair of the department as he reaches the midway point of his tenure.
William Morice, M.D., Ph.D., President of Mayo Clinic Laboratories (MCL)and Chair of the Department of Laboratory Medicine and Pathology (DLMP), sits down with Dr. Anil Parwani from Ohio State University to talk about digital pathology.
Mayo Medical Laboratories (MML) President William Morice, M.D., Ph.D., sits down with Scott Beck, Senior Vice President of MML, to welcome him into his new role.
Mayo Medical Laboratories President William Morice, M.D., Ph.D., sits down with Benjamin Kipp, Ph.D., Director of the Advanced Diagnostic Laboratory at Mayo Clinic in Rochester, Minnesota, to learn more about the lab's research and purpose.
Mayo Medical Laboratories President William Morice, M.D., Ph.D., sits down with the Daryl Kor, M.D., Medical Director of Patient Blood Management and Consultant in the Department of Anesthesiology at Mayo Clinic in Rochester. The two discuss CareSelect Blood, a patient blood-management solution that improves patient blood health, guides health care providers on the proper utilization of blood products, and reduces the cost of care.
Mayo Medical Laboratories President William Morice, M.D., Ph.D., sits down with the new Medical Director of Mayo Medical Laboratories, Mohamed Salama, M.D. The two discuss his role and career history.
William Morice, II, M.D., Ph.D., sat down with Marie Brown to recap her time spent at Mayo Clinic and wish her well in her retirement.
Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.
Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.
Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.
Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.
Jane Hermansen is the manager for the Mayo Medical Laboratories Outreach and Network Development Program and the chair for the Leveraging the Laboratory Conference taking place on September 18-19, 2018 in Rochester, Minnesota.
Andrew McKeon, M.D., M.B., B.Ch. and Eati Basal, Ph.D. discuss their presentation during the MS and CNS Inflammatory Disease: Basic session at AAN 2018.
Shirley Roque is an Outreach Program Coordinator for Mayo Medical Laboratories and is on the planning committee for the Leveraging the Laboratory Conference that is taking place on September 18-19, 2018 in Rochester, Minnesota.
A. Sebastian Lopez Chiriboga, M.D. discusses his presentation during the Neuromyelitis Optica Spectrum Disorder and other Autoimmune Disorders session during AAN 2018.
Christopher Klein, a Neurologist at Mayo Clinic, provides an overview of neuromuscular testing through Mayo Medical Laboratories. He discusses which types of patients should be tested, the benefits of our approach, how this approach improves upon previous methods, and the role that functional assays play in diagnosis.
Christopher Klein, a Neurologist at Mayo Clinic, provides an overview of neuromuscular testing through Mayo Medical Laboratories. He discusses which types of patients should be tested, the benefits of our approach, how this approach improves upon previous methods, and the role that functional assays play in diagnosis.
Christopher Klein, a Neurologist at Mayo Clinic, provides an overview of neuromuscular testing through Mayo Medical Laboratories. He discusses which types of patients should be tested, the benefits of our approach, how this approach improves upon previous methods, and the role that functional assays play in diagnosis.
William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic in Rochester, Minnesota, and President of Mayo Medical Laboratories, sits down with Gina Chiri-Osmond, Marketing Channel Manager at Mayo Medical Laboratories, to talk about “The Innovator’s Dilemma” by Clayton Christensen.
Nicole Kang, one of the speakers for the 2018 Phlebotomy Conference, provides a snapshot of what her breakout session geared towards phlebotomy managers and supervisors will entail.
Mary Kaye Peterson, one of the Course Directors for the 2018 Phlebotomy Conference, provides an overview of the upcoming conference held in Rochester, Minnesota, March 22-23, 2018.
James Stubbs, M.D., provides an overview of the upcoming TransFuse Conference in San Antonio, Texas.
Justin Kreuter, M.D., provides an overview of the upcoming TransFuse Conference in San Antonio, Texas.
Audio Insights with Dr. Morice: Bobbi Pritt, M.D. (Part 2) by Mayo Medical Laboratories
Audio Insights with Dr. Morice: Bobbi Pritt, M.D. (Part 1) by Mayo Medical Laboratories
On November 15, Mayo Clinic experts will share tips to help your hospital prepare for an RFP. Take a listen to why you should participate in this insightful webinar.
Mayo Medical Laboratories President William Morice, M.D., Ph.D., sits down with Andrew Feldman, M.D., Vice Chair for Research in the Department of Laboratory Medicine and Pathology at Mayo Clinic.
Jane Hermansen, Network Manager at Mayo Medical Laboratories, talks about the upcoming Leveraging the Laboratory conference in Philadelphia, Pennsylvania.
Sue Cloutier, Operations Manager, and Julie Bicknese, Supervisor, at Mayo Clinic, talk about their upcoming breakout session on leveraging customer service at Leveraging the Laboratory 2017 in Philadelphia, Pennsylvania.
Sharon Zehe, Legal Counsel at Mayo Clinic, talks about her upcoming breakout session on legal updates at Leveraging the Laboratory 2017 in Philadelphia, Pennsylvania.
Mike Baisch, Principal Systems Engineer at Mayo Clinic, talks about his upcoming breakout session on staffing to workload at Leveraging the Laboratory 2017 in Philadelphia, Pennsylvania.
Gessi Bentz Pino, CGS, a Genetic Counselor in the Department of Laboratory Medicine and Pathology at Mayo Clinic, provides an overview of the lysosomal storage disorders screen.
Gessi Bentz Pino, CGS, a Genetic Counselor in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses the drawbacks of the Lysosomal Storage Disorders Screen.
Gessi Bentz Pino, CGS, a Genetic Counselor in the Department of Laboratory Medicine and Pathology at Mayo Clinic discusses how this test improves upon previous approaches to Lysosomal Storage Disorder screening.
Gessi Bentz Pino, CGS, a Genetic Counselor in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses what clinical actions the results allow you to take.
Gessi Bentz Pino, CGS, a Genetic Counselor in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses when it is appropriate to order this test.
Mayo Medical Laboratories President William Morice, M.D., Ph.D., sits down with the new chair of the Mayo Clinic Division of Anatomic Pathology, Amy Clayton, M.D. The two discuss the role, leadership, and a shared history.
On Tuesday, we had a quick conversation with Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D. We discussed their presentations and sessions.
One of our busiest laboratory directors, Melissa Snyder, Ph.D., spent a couple spare minutes with us to discuss her presentations and what she looks forward to most at AACC.
After her morning symposium yesterday, we ran into Linnea Baudhuin, Ph.D., who presented, "Bigger Always Better? Pros and Cons of Targeted vs Comprehensive Genetic Testing." Her co-presenter was Carol Saunders, Ph.D. She ended our conversation by previewing Tuesday's, "Laboratory Medicine Family Feud: AACC Leadership vs SYCL" symposium.
We caught up with Maria Alice Willrich, Ph.D., who presented a mid-day short course on Monday, July 31. The course was titled, "The Complement System: Overview and Laboratory Testing" and she co-presented with a colleague from the University of Colorado, Ashley Frazer-Abel, Ph.D.
Pat Hlavka, CSP, Safety Coordinator, and Deb Hagen-Moe, Education Coordinator, discuss a variety of safety education resources and training at Mayo Clinic.
Nicole Hoppman, Ph.D. discusses advantages of the Cell-Free DNA Prenatal Screen. This test detects common chromosome abnormalities without the risk of pregnancy loss associated with invasive prenatal procedures. Chromosomal aneuploidy is the leading known genetic cause of miscarriage and congenital birth defects, including Down syndrome, trisomy 13, and trisomy 18.
This fetal DNA screening test is not diagnostic. Abnormal results should be confirmed with invasive prenatal diagnostic testing (such as chorionic villi sampling or amniocentesis). Genetic consultation is recommended.
Nicole Hoppman, Ph.D. discusses clinical application of Cell-Free DNA Prenatal Screen. This test detects common chromosome abnormalities without the risk of pregnancy loss associated with invasive prenatal procedures. Chromosomal aneuploidy is the leading known genetic cause of miscarriage and congenital birth defects, including Down syndrome, trisomy 13, and trisomy 18.
This fetal DNA screening test is not diagnostic. Abnormal results should be confirmed with invasive prenatal diagnostic testing (such as chorionic villi sampling or amniocentesis). Genetic consultation is recommended.
Nicole Hoppman, Ph.D. discusses ordering scenarios of the Cell-Free DNA Prenatal Screen. This test detects common chromosome abnormalities without the risk of pregnancy loss associated with invasive prenatal procedures. Chromosomal aneuploidy is the leading known genetic cause of miscarriage and congenital birth defects, including Down syndrome, trisomy 13, and trisomy 18.
This fetal DNA screening test is not diagnostic. Abnormal results should be confirmed with invasive prenatal diagnostic testing (such as chorionic villi sampling or amniocentesis). Genetic consultation is recommended.
Nicole Hoppman, Ph.D. provides an overview of the Cell-Free DNA Prenatal Screen. This test detects common chromosome abnormalities without the risk of pregnancy loss associated with invasive prenatal procedures. Chromosomal aneuploidy is the leading known genetic cause of miscarriage and congenital birth defects, including Down syndrome, trisomy 13, and trisomy 18.
This fetal DNA screening test is not diagnostic. Abnormal results should be confirmed with invasive prenatal diagnostic testing (such as chorionic villi sampling or amniocentesis). Genetic consultation is recommended.
Dietrich Matern, M.D., Ph.D., Chair of the Division of Laboratory Genetics and a Consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic, provides an overview of newborn screening.
Dietrich Matern, M.D., Ph.D., Chair of the Division of Laboratory Genetics and a Consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses Mayo Clinic's efforts to reduce false positives in Newborn Screening
Dietrich Matern, M.D., Ph.D., Chair of the Division of Laboratory Genetics and a Consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses the clinical action enabled by newborn screening.
Dietrich Matern, M.D., Ph.D., Chair of the Division of Laboratory Genetics and a Consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discuss the RUSP and its importance in newborn screening.
Learn how Mayo Clinic researchers discovered a new bacterial species that causes Lyme disease in people.
We connected with Henry D. Tazelaar, M.D., chair of the Mayo Clinic Green Advisory Council to discuss ongoing efforts to Mayo's sustainability initiatives. The interview was conducted over Skype.
We recently sat down with Jane Hermansen, Network and Outreach Development Manager at Mayo Clinic Medical Laboratories in Rochester, Minnesota, to discuss Clinical Laboratory Management Association's (CLMA) upcoming KnowledgeLab 2017, held March 26-29 in Nashville, TN.